The HYDRATION Study
- Study HIC#:2000033279
- Last Updated:09/08/2024
The HYDRATION Study (Hydration at Yale During Radiography and Treatment of Iliac Obstruction) will assess the impact of intravenous fluid administration on the size and morphology of pelvic veins. This study will assess how the variation in hydration status affects the diameter of the pelvic veins and how this change in vein size impacts the detection of venous lesions causing outflow obstruction. Participants will complete a screening questionnaire, which includes health-related questions. They will then undergo two magnetic resonance venographies with contrast before and after administration of a pre-specified volume of fluid via intravenous cannulation. The study will take between two and three hours for participants to complete.
Contact Us
For more information about this study, including how to volunteer, contact:
Kurt Schultz, MD
- Phone Number: 1-508-479-3427
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.
Trial Purpose and Description
The HYDRATION Study (Hydration at Yale During Radiography and Treatment of Iliac Obstruction) will assess the impact of intravenous fluid administration on the size and morphology of pelvic veins. This study will assess how the variation in hydration status affects the diameter of the pelvic veins and how this change in vein size impacts the detection of venous lesions causing outflow obstruction. Participants will complete a screening questionnaire, which includes health-related questions. They will then undergo two magnetic resonance venographies with contrast before and after administration of a pre-specified volume of fluid via intravenous cannulation. The study will take between two and three hours for participants to complete.
Eligibility Criteria
Adults between 18 and 60 years of age without cardiovascular health problems, specifically with no lower extremity vascular-related signs or symptoms.
Principal Investigator
- Score: 1
